Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

42 trials with published results (21%)

Research Maturity

151 completed trials (75% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.0%

6 terminated out of 201 trials

Success Rate

96.2%

+9.7% vs benchmark

Late-Stage Pipeline

29%

58 trials in Phase 3/4

Results Transparency

28%

42 of 151 completed with results

Key Signals

42 with results96% success

Data Visualizations

Phase Distribution

164Total
Not Applicable (72)
P 1 (7)
P 2 (27)
P 3 (25)
P 4 (33)

Trial Status

Completed151
Unknown26
Terminated6
Recruiting6
Withdrawn4
Active Not Recruiting4

Trial Success Rate

96.2%

Benchmark: 86.5%

Based on 151 completed trials

Clinical Trials (201)

Showing 20 of 20 trials
NCT00001246Active Not Recruiting

Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers

NCT05924594Phase 3Suspended

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

NCT05308706Not ApplicableActive Not RecruitingPrimary

Efficacy of the Apollo System for Children With ADHD

NCT07442058Not ApplicableNot Yet RecruitingPrimary

Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD

NCT01876524Not ApplicableCompleted

tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients

NCT06679010Not ApplicableCompleted

A Feasibility Study of AMOR; ADHD, Mothers Online Resources

NCT02364817Completed

ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse

NCT05354232Not ApplicableRecruiting

Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

NCT07253441Phase 1CompletedPrimary

A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels

NCT00626236Phase 2CompletedPrimary

Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems

NCT06063382Not ApplicableCompletedPrimary

Extra Time on Brazilian College Level Exam for Students With and Without ADHD

NCT03511976Phase 4WithdrawnPrimary

Adaptive Response to Intervention (RTI) for Students With ADHD

NCT02348073Phase 3CompletedPrimary

Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy

NCT06946433Not ApplicableCompleted

tDCS in Adults With ASD and/or ADHD Without Intellectual Disability

NCT04132557CompletedPrimary

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

NCT06369714Not ApplicableRecruitingPrimary

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

NCT06974136Not ApplicableRecruitingPrimary

tES Modalities for the Treatment of ADHD

NCT06970418CompletedPrimary

Sleep Disorders, Chronotype, and Functional Impairment in the Restrictive ADHD Phenotype

NCT04113551CompletedPrimary

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan

NCT06670092Not ApplicableCompletedPrimary

Effect of Vojta Therapy on Motor Control in Children With Attention Deficit Hyperactivity Disorder

Scroll to load more

Research Network

Activity Timeline